Robert Hombach, EVP, CFO and COO at Baxalta Incorporated, holds 13.00K shares in Seaport Therapeutics, Inc. (Ticker: SPTX), holds 49.36K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 5.42K shares in Henry Schein (Ticker: HSIC). Most recently, Robert Hombach Bought ― shares of Seaport Therapeutics, Inc. on Jun 24, 2026 for an estimated value of $235.69K.
Robert Hombach latest transaction was an Informative Buy of $235.69K.
What was Robert Hombach's most profitable transaction?
Robert Hombach’s most profitable transaction was an Informative Buy of APTX stock on January 14, 2020. The return on the trade was 17.50%.
What is Robert Hombach's role in Baxalta Incorporated?
Robert Hombach's role in Baxalta Incorporated is EVP, CFO and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.